Clinical trial
10119473 -VIROMARKERS HDV Biomarkers Study
NCT07313358 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 10119473 -VIROMARKERS HDV Biomarkers Study
- Lead sponsor
- University of Rome Tor Vergata
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 20, 2026
- Completion date
- October 30, 2026
- Enrollment
- 220 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hdv infection